MENU
+Compare
SIGY
Stock ticker: OTC
AS OF
Jul 11 closing price
Price
$2.80
Change
+$0.05 (+1.82%)
Capitalization
4.5M

SIGY Sigyn Therapeutics Inc. Forecast, Technical & Fundamental Analysis

Sigyn Therapeutics Inc is a development-stage therapeutic technology company... Show more

SIGY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for SIGY with price predictions
Jul 21, 2025

SIGY's Stochastic Oscillator remains in overbought zone for 4 days

The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis
Bullish Trend Analysis

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly better than average price growth. SIGY’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.000) is normal, around the industry mean (18.131). P/E Ratio (0.000) is within average values for comparable stocks, (58.574). SIGY's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.444). Dividend Yield (0.000) settles around the average of (0.043) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (274.844).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SIGY’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
SIGY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
2468 Historic Decatur Road
Phone
+1 619 353-0800
Employees
5
Web
https://www.sigyntherapeutics.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PHR26.551.07
+4.20%
Phreesia
VNCE1.500.03
+2.04%
VINCE HOLDING Corp
VFC12.450.19
+1.55%
VF Corp
SENS0.58N/A
-0.36%
Senseonics Holdings
BKNG5677.15-25.75
-0.45%
Booking Holdings

SIGY and Stocks

Correlation & Price change

A.I.dvisor tells us that SIGY and ELVAF have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SIGY and ELVAF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SIGY
1D Price
Change %
SIGY100%
N/A
ELVAF - SIGY
31%
Poorly correlated
N/A
IVVD - SIGY
20%
Poorly correlated
+3.01%
CLYYF - SIGY
12%
Poorly correlated
N/A
NBTX - SIGY
11%
Poorly correlated
-3.58%
CPMV - SIGY
6%
Poorly correlated
N/A
More